v3.26.1
Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Reconciliation of Cash and Cash Equivalents
The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:
In millionsJune 30,
2026		December 31,
2025
Cash and cash equivalents$11,329 $8,453 
Restricted cash (included in other current assets)— 59 
Restricted cash (included in other assets)208 200 
Total cash, cash equivalents and restricted cash in the statements of cash flows$11,537 $8,712 
Schedule of Accounts Receivable, Net Accounts receivable, net as of June 30, 2026 and December 31, 2025 was composed of the following:
In millionsJune 30,
2026		December 31,
2025
Trade receivables$12,985 $10,563 
Vendor and manufacturer receivables14,818 15,564 
Premium receivables6,395 5,753 
Other receivables6,111 7,899 
   Total accounts receivable, net$40,309 $39,779 
Schedule of Disaggregation of Revenue
The following tables disaggregate the Company’s revenue by major source in each segment for the three and six months ended June 30, 2026 and 2025:
In millionsHealth Care
Benefits		Health
Services		Pharmacy &
Consumer
Wellness 		Corporate/
Other		Intersegment
Eliminations		Consolidated
Totals
Three Months Ended June 30, 2026
Major goods/services lines:
Pharmacy$— $49,194 $27,781 $— $(16,149)$60,826 
Front Store— — 5,407 — — 5,407 
Premiums35,119 — — 11 (13)35,117 
Net investment income (loss)508 (1)— 134 — 641 
Other1,911 2,602 628 2 (1,038)4,105 
Total$37,538 $51,795 $33,816 $147 $(17,200)$106,096 
Health Services distribution channel:
Pharmacy network (1)
$26,617 
Mail & specialty (2)
22,577 
Net investment income (loss)(1)
Other2,602 
Total$51,795 
Three Months Ended June 30, 2025
Major goods/services lines:
Pharmacy$— $44,276 $27,631 $— $(16,558)$55,349 
Front Store— — 5,368 — — 5,368 
Premiums34,184 — — 11 — 34,195 
Net investment income (loss)407 (3)— 83 — 487 
Other1,667 2,180 582 2 (915)3,516 
Total$36,258 $46,453 $33,581 $96 $(17,473)$98,915 
Health Services distribution channel:
Pharmacy network (1)
$24,665 
Mail & specialty (2)
19,611 
Net investment income (loss)(3)
Other2,180 
Total$46,453 
In millionsHealth Care
Benefits		Health
Services		Pharmacy &
Consumer
Wellness 		Corporate/
Other		Intersegment
Eliminations		Consolidated
Totals
Six Months Ended June 30, 2026
Major goods/services lines:
Pharmacy$— $94,849 $53,904 $— $(30,988)$117,765 
Front Store— — 10,666 — — 10,666 
Premiums68,911 — — 23 (26)68,908 
Net investment income (loss)970 (1)— 246 — 1,215 
Other3,628 5,184 1,235 4 (2,083)7,968 
Total$73,509 $100,032 $65,805 $273 $(33,097)$206,522 
Health Services distribution channel:
Pharmacy network (1)
$51,766 
Mail & specialty (2)
43,083 
Net investment income (loss)(1)
Other5,184 
Total$100,032 
Six Months Ended June 30, 2025
Major goods/services lines:
Pharmacy$— $85,458 $53,707 $— $(31,309)$107,856 
Front Store— — 10,611 — — 10,611 
Premiums66,992 — — 23 — 67,015 
Net investment income794 11 — 202 — 1,007 
Other3,282 4,446 1,175 4 (1,893)7,014 
Total$71,068 $89,915 $65,493 $229 $(33,202)$193,503 
Health Services distribution channel:
Pharmacy network (1)
$47,779 
Mail & specialty (2)
37,679 
Net investment income11 
Other4,446 
Total$89,915 
_____________________________________________
(1)Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including pharmacies owned by the Company, as well as activity associated with Maintenance Choice®, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.
(2)Health Services mail & specialty is defined as specialty mail claims inclusive of Specialty Connect® claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy & Consumer Wellness segment.